Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - james+moe
1
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Recombinant Antibody Fragments that Selectively Target Oligomeric Tau Aggregates
Alzheimer's disease (AD) is one of the most prevalent and feared neurodegenerative diseases associated with aging, characterized by progressive neuronal loss and cognitive dysfunction. AD affects nearly 5 million Americans, and unfortunately, there is no cure as of yet. Numerous studies have implicated oligomeric amyloid beta (Aß) aggregates as...
Published: 4/19/2023
|
Inventor(s):
Michael Sierks
,
Huilai Tian
,
James Moe
,
Eliot Davidowitz
Keywords(s):
Antibodies
,
Antibody Therapeutics
,
Antigen-specific Therapies
,
Bioassay
,
Dementias
,
Diagnostics
,
Human aging
,
Protein
,
Therapeutics
Category(s):
Life Science (All LS Techs)
,
Neurodegenerative Disease Technologies
,
Non-Cancer Therapeutics
,
Diagnostic Assays/Devices
,
Medical Diagnostics/Sensors
,
Proteomic Assays/Reagents/Tools